164 related articles for article (PubMed ID: 9435164)
1. The role of platelet-activating factor (PAF) and the efficacy of ABT-491, a highly potent and selective PAF antagonist, in experimental allergic rhinitis.
Albert DH; Malo PE; Tapang P; Shaughnessy TK; Morgan DW; Wegner CD; Curtin ML; Sheppard GS; Xu L; Davidsen SK; Summers JB; Carter GW
J Pharmacol Exp Ther; 1998 Jan; 284(1):83-8. PubMed ID: 9435164
[TBL] [Abstract][Full Text] [Related]
2. ABT-491, a highly potent and selective PAF antagonist, inhibits nasal vascular permeability associated with experimental allergic rhinitis in brown Norway rats.
Albert DH; Tapang P; Morgan DW; Curtin ML; Sheppard GS; Davidsen SK; Summers JB; Carter GW
Inflamm Res; 1997 Aug; 46 Suppl 2():S133-4. PubMed ID: 9297547
[No Abstract] [Full Text] [Related]
3. Pharmacology of ABT-491, a highly potent platelet-activating factor receptor antagonist.
Albert DH; Magoc TJ; Tapang P; Luo G; Morgan DW; Curtin M; Sheppard GS; Xu L; Heyman HR; Davidsen SK; Summers JB; Carter GW
Eur J Pharmacol; 1997 Apr; 325(1):69-80. PubMed ID: 9151941
[TBL] [Abstract][Full Text] [Related]
4. The effect of the selective PAF antagonist CIS-19 on PAF- and antigen-induced bronchoconstriction, microvascular leakage and bronchial hyperreactivity in guinea-pigs.
Lin CH; Ko FN; Ishii H; Ishikawa T; Chen IS; Teng CM; Kuo HP
Naunyn Schmiedebergs Arch Pharmacol; 1997 Feb; 355(2):210-6. PubMed ID: 9050014
[TBL] [Abstract][Full Text] [Related]
5. Platelet-activating factor (PAF)-induced rhinitis and involvement of PAF in allergic rhinitis in guinea pigs.
Misawa M; Iwamura S
Jpn J Pharmacol; 1990 Oct; 54(2):217-26. PubMed ID: 2077186
[TBL] [Abstract][Full Text] [Related]
6. [Effects of anti-PAF agents on nasal response after allergen challenge in guinea pigs].
Narita S; Asakura K; Shirasaki H; Kojima T; Saitoh H; Kataura A
Nihon Jibiinkoka Gakkai Kaiho; 1992 Aug; 95(8):1190-7. PubMed ID: 1357119
[TBL] [Abstract][Full Text] [Related]
7. The effects of anti-PAF and other agents on the nasal symptoms in sensitized guinea pigs.
Narita S; Asakura K
Auris Nasus Larynx; 1993; 20(3):175-83. PubMed ID: 7905260
[TBL] [Abstract][Full Text] [Related]
8. Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent.
Levrier J; Duval D; Prouteau M; Voltz C; Berry CN; Lloyd KG; Scatton B
Arzneimittelforschung; 1995 May; 45(5):559-68. PubMed ID: 7541995
[TBL] [Abstract][Full Text] [Related]
9. Properties of ABT-299, a prodrug of A-85783, a highly potent platelet activating factor receptor antagonist.
Albert DH; Conway RG; Magoc TJ; Tapang P; Rhein DA; Luo G; Holms JH; Davidsen SK; Summers JB; Carter GW
J Pharmacol Exp Ther; 1996 Jun; 277(3):1595-606. PubMed ID: 8667228
[TBL] [Abstract][Full Text] [Related]
10. Effect of a Paf antagonist, WEB 2086, on airway microvascular leakage in the guinea-pig and platelet aggregation in man.
Evans TW; Dent G; Rogers DF; Aursudkij B; Chung KF; Barnes PJ
Br J Pharmacol; 1988 May; 94(1):164-8. PubMed ID: 3401633
[TBL] [Abstract][Full Text] [Related]
11. [Involvement of platelet activating factor (PAF) in ovalbumin antigen-induced late asthmatic response and increase of airway hyperresponsiveness in a guinea pig experimental model of asthma].
Arima M; Yukawa T; Terashi Y; Sagara H; Makino S
Arerugi; 1991 Feb; 40(2):141-6. PubMed ID: 2069513
[TBL] [Abstract][Full Text] [Related]
12. Pharmacologic activity of bepafant (WEB 2170), a new and selective hetrazepinoic antagonist of platelet activating factor.
Heuer HO; Casals-Stenzel J; Muacevic G; Weber KH
J Pharmacol Exp Ther; 1990 Dec; 255(3):962-8. PubMed ID: 2262914
[TBL] [Abstract][Full Text] [Related]
13. Effects of fexofenadine hydrochloride in a guinea pig model of antigen-induced rhinitis.
Sakairi T; Suzuki K; Makita S; Wajima T; Shakuto S; Yoshida Y; Yaguchi M
Pharmacology; 2005 Oct; 75(2):76-86. PubMed ID: 16037679
[TBL] [Abstract][Full Text] [Related]
14. Role of PAF in the late airway microvascular leakage induced by antigen in IgE-sensitized rat.
Kyriacopoulos F; Boichot E; Lagente V; Mencia-Huerta JM; Braquet P
Fundam Clin Pharmacol; 1995; 9(4):350-6. PubMed ID: 8566934
[TBL] [Abstract][Full Text] [Related]
15. [Effect of platelet-activating factor on nasal vascular permeability and eosinophil accumulation in guinea pigs].
Shirasaki H; Asakura K
Nihon Jibiinkoka Gakkai Kaiho; 1990 Apr; 93(4):615-21. PubMed ID: 2376799
[TBL] [Abstract][Full Text] [Related]
16. UK-74,505, a novel and selective PAF antagonist, exhibits potent and long lasting activity in vivo.
Alabaster VA; Keir RF; Parry MJ; de Souza RN
Agents Actions Suppl; 1991; 34():221-7. PubMed ID: 1793066
[TBL] [Abstract][Full Text] [Related]
17. Effect of inhaled lyso-platelet-activating factor on airway microvascular leakage in the guinea pig.
Sakamoto T; Elwood W; Barnes PJ; Chung KF
J Appl Physiol (1985); 1993 Mar; 74(3):1117-22. PubMed ID: 8482649
[TBL] [Abstract][Full Text] [Related]
18. Effect of Y-24180, a platelet-activating factor-receptor antagonist, on the antigen-induced airway microvascular leakage in guinea pigs.
Iwahisa Y; Yamaguchi S; Kagoshima M; Terasawa M
Jpn J Pharmacol; 1996 Nov; 72(3):209-15. PubMed ID: 8957681
[TBL] [Abstract][Full Text] [Related]
19. [Effect of amlexanox on experimental allergic rhinitis in actively sensitized guinea pigs].
Ukai K; Atsushi ; Yuda ; Nonoyama T; Sakakura Y; Ahida Y
Arerugi; 1990 Jan; 39(1):54-8. PubMed ID: 2350243
[TBL] [Abstract][Full Text] [Related]
20. The role of platelet activating factor and the efficacy of apafant ophthalmic solution in experimental allergic conjunctivitis.
Kato M; Kurose T; Oda T; Miyaji S
J Ocul Pharmacol Ther; 2003 Aug; 19(4):315-24. PubMed ID: 12964956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
